Announcement on Proposal from Controlling Shareholders to Repurchase Shares, Implement Medium-term Dividend in 2024 and Promote "Corporate Value and Return Enhancement" Action Plan
· Issued by Nanjing Medlander Medical Technology Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Proposal from Controlling Shareholders to Repurchase Shares, Implement Medium-term Dividend in 2024 and Promote "Corporate Value and Return Enhancement" Action Plan
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
